Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke

Journal of the Neurological Sciences

Volumn 233, Issue 1-2, 2005, Pages 125-132

  Frenkel, Dan ^a   Huang, Zhihong ^a,b   Maron, Ruth ^a   Koldzic, Djordje N ^a   Moskowitz, Michael A ^a,b   Weiner, Howard L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

IL 10; Mucosa; Myelin oligodendrocyte glycoprotein; Stroke; T cells; Tolerance

Indexed keywords

INTERLEUKIN 10; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BEHAVIOR; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; IMMUNOHISTOLOGY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD; BEHAVIOR, ANIMAL; BRAIN INFARCTION; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CEREBROVASCULAR ACCIDENT; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; PEPTIDE FRAGMENTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 20444371569     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2005.03.022     Document Type: Conference Paper

References (40)

1. D.C. Johnston, and M.D. Hill The patient with transient cerebral ischemia: a golden opportunity for stroke prevention CMAJ 170 2004 1134 1137
2. K.A. Hossmann Viability thresholds and the penumbra of focal ischemia Ann Neurol 36 1994 557 565
3. R.M. Friedlander Apoptosis and caspases in neurodegenerative diseases N Engl J Med 348 2003 1365 1375
4. W.J. Koroshetz, and M.A. Moskowitz Emerging treatments for stroke in humans Trends Pharmacol Sci 17 1996 227 233
5. H.L. Li, N. Kostulas, Y.M. Huang, B.G. Xiao, P. van der Meide, and V. Kostulas IL-17 and IFN-gamma mRNA expression is increased in the brain and systemically after permanent middle cerebral artery occlusion in the rat J Neuroimmunol 116 2001 5 14
6. E.S. Connolly Jr., C.J. Winfree, C.J. Prestigiacomo, S.C. Kim, T.F. Choudhri, and B.L. Hoh Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke Circ Res 81 1997 304 310
7. R.L. Zhang, M. Chopp, Y. Li, C. Zaloga, N. Jiang, and M.L. Jones Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat Neurology 44 1994 1747 1751
8. G.J. del Zoppo, K.J. Becker, and J.M. Hallenbeck Inflammation after stroke: is it harmful? Arch Neurol 58 2001 669 672
9. H. Weiner Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells Immunol Rev 182 2001 207 214
10. H. Groux An overview of regulatory T cells Microbes Infect 3 2001 883 889
11. H.L. Weiner The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells Nat Immunol 2 2001 671 672
12. N. Vila, J. Castillo, A. Davalos, A. Esteve, A.M. Planas, and A. Chamorro Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke Stroke 34 2003 671 675
13. E. van Exel, J. Gussekloo, A.J. de Craen, A. Bootsma-van der Wiel, M. Frolich, and R.G. Westendorp Inflammation and stroke: the Leiden 85-Plus Study Stroke 33 2002 1135 1138
14. J. Krupinski, P. Kumar, S. Kumar, and J. Kaluza Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans Stroke 27 1996 852 857
15. K.J. Becker, R.M. McCarron, C. Ruetzler, O. Laban, E. Sternberg, and K.C. Flanders Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia Proc Natl Acad Sci U S A 94 1997 10873 10878
16. G. Birnbaum, and L. Kotilinek Immunologic differences in murine glial cells and their association with susceptibility to experimental allergic encephalomyelitis J Neuroimmunol 26 1990 119 129
17. J. Inobe, A.J. Slavin, Y. Komagata, Y. Chen, L. Liu, and H.L. Weiner IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis Eur J Immunol 28 1998 2780 2790
18. Z. Huang, P.L. Huang, N. Panahian, T. Dalkara, M.C. Fishman, and M.A. Moskowitz Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase Science 265 1994 1883 1885
19. Z. Huang, P.L. Huang, J. Ma, W. Meng, C. Ayata, and M.C. Fishman Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-l-arginine J Cereb Blood Flow Metab 16 1996 981 987
20. M. Endres, Z.Q. Wang, S. Namura, C. Waeber, and M.A. Moskowitz Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase J Cereb Blood Flow Metab 17 1997 1143 1151
21. R. Maron, A.M.C. Faria, and H.L. Weiner Oral tolerogen generation in nude and B-cell-knockout mice after feeding a high dose ovalbumin FASEB J 1999 13
22. S.J. Khoury, W.W. Hancock, and H.L. Weiner Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis as associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor b, interleukin 4, and prostaglandin E expression in the brain J Exp Med 176 1992 1355 1364
23. E. Bettelli, M.P. Das, E.D. Howard, H.L. Weiner, R.A. Sobel, and V.K. Kuchroo IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice J Immunol 161 1998 3299 3306
24. E. Yoles, E. Hauben, O. Palgi, E. Agranov, A. Gothilf, and A. Cohen Protective autoimmunity is a physiological response to CNS trauma J Neurosci 21 2001 3740 3748
25. R. Barouch, and M. Schwartz Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity FASEB J 16 2002 1304 1306
26. G. Moalem, R. Leibowitz-Amit, E. Yoles, F. Mor, I.R. Cohen, and M. Schwartz Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy Nat Med 5 1999 49 55
27. H.C. Emsley, and P.J. Tyrrell Inflammation and infection in clinical stroke J Cereb Blood Flow Metab 22 2002 1399 1419
28. A.M.C. Faria, and H.L. Weiner Oral tolerance: mechanisms and therapeutic applications Adv Immunol 73 1999 153 264
29. K.J.M.R. Becker, C. Ruetzler, O. Laban, E. Sternberg, K.C. Flanders, and J.M. Hallenbeck Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia Proc Natl Acad Sci U S A 94 1997 10873 10878
30. G. Hall, C.G. Houghton, J.U. Rahbek, J.R. Lamb, and E.R. Jarman Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production Vaccine 21 2003 549 561
31. E.G.J. van Exel, A.J. de Craen, A. Bootsma-van der Wiel, M. Frolich, and R.G. Westendorp Inflammation and stroke: the Leiden 85-Plus Study Stroke 2002 33
32. G.J. del Zoppo, K.J. Becker, and J.M. Hallenbeck Inflammation after stroke: is it harmful? Arch Neurol 58 2001 669 672
33. R. Maron, G.K. Sukhova, A.M. Faria, E. Hoffman, F. Mach, and P. Libby Mucosal administration of HSP 65 decreases atherosclerosis and inflammation in the aortic arch of LDL receptor deficient mice FASEB J 2000 A1199
34. A. Bachis, A.M. Colangelo, S. Vicini, P.P. Doe, M.A. De Bernardi, and G. Brooker Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity J Neurosci 21 2001 3104 3112
35. A. Schneider, A. Martin-Villalba, F. Weih, J. Vogel, T. Wirth, and M. Schwaninger NF-kappaB is activated and promotes cell death in focal cerebral ischemia Nat Med 5 1999 554 559
36. E.H. Field, D. Matesic, S. Rigby, T. Fehr, T. Rouse, and Q. Gao CD4+CD25+ regulatory cells in acquired MHC tolerance Immunol Rev 182 2001 99 112
37. D. Frenkel, Z. Huang, R. Maron, D.N. Koldzic, W.W. Hancock, and M.A. Moskowitz Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells J Immunol 171 2003 6549 6555
38. K. Becker, D. Kindrick, R. McCarron, J. Hallenbeck, and R. Winn Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury? Stroke 34 2003 1809 1815
39. Y. Chen, C. Ruetzler, S. Pandipati, M. Spatz, R.M. McCarron, and K. Becker Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury Proc Natl Acad Sci U S A 100 2003 15107 15112
40. M. Schwartz T cell mediated neuroprotection is a physiological response to central nervous system insults J Mol Med 78 2001 594 597